The most common semaglutide side effects are gastrointestinal, including nausea, diarrhea, vomiting, constipation and abdominal discomfort. Some reactions can be serious. Current prescribing information also warns about pancreatitis, gallbladder disease, dehydration-related kidney injury, severe gastrointestinal reactions, hypersensitivity and other product-specific risks.
This article is for general educational information and is not a substitute for diagnosis, prescribing, dosing or individualized medical advice. Semaglutide is a prescription medicine. Product indications and instructions differ by formulation. Readers should use the exact current prescribing information and speak with a licensed healthcare professional. |
The most common side effects are digestive
In current Wegovy labeling, common adverse reactions include nausea, diarrhea, vomiting, constipation and abdominal pain, along with symptoms such as indigestion, abdominal distension and reflux. These effects are often more noticeable during dose escalation.
A side effect being common does not mean it should be ignored. Persistent vomiting or diarrhea can lead to dehydration, which can contribute to kidney injury in some patients.
Why gradual dose escalation is used
Semaglutide exposure is typically increased step by step in approved regimens. One reason is to reduce the risk of gastrointestinal adverse reactions while the body adjusts.
Taking more than prescribed, measuring compounded products incorrectly or accelerating a schedule without clinical guidance can increase risk rather than improve outcomes.
Important symptoms that deserve prompt attention
Severe, persistent abdominal pain may require evaluation for pancreatitis. Symptoms suggesting gallbladder disease, serious allergic reaction, significant dehydration or another acute problem should be assessed promptly. People with diabetes should also follow product-specific advice about glucose and eye complications.
Before surgery or deep sedation, the care team should know about GLP-1 use because delayed gastric emptying has been associated with rare reports of pulmonary aspiration despite fasting.
The thyroid boxed warning
Wegovy carries a boxed warning because semaglutide caused thyroid C-cell tumors in rodents. It is unknown whether this occurs in humans. The medicine is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
This is an example of why online checklists cannot replace a medical history.
Side effects should be managed, not normalized
People sometimes assume that severe nausea means the medication is working. That is not a safe rule. Treatment should be tolerable enough to support hydration, nutrition and daily life.
If side effects are interfering with eating, drinking or normal function, the prescriber may need to reassess the plan. Do not change dose or stop an important medicine without appropriate guidance unless emergency care is needed.
Frequently Asked Questions
What is the most common side effect of semaglutide?
Gastrointestinal effects are most common, especially nausea, diarrhea, vomiting, constipation and abdominal discomfort.
Can semaglutide cause dehydration?
Yes. Vomiting or diarrhea can lead to dehydration, which may contribute to kidney injury in some patients.
Does semaglutide have a thyroid warning?
Yes. Wegovy carries a boxed warning related to thyroid C-cell tumors seen in rodents and is contraindicated in people with MTC history or MEN 2.
When should I call a doctor about side effects?
Seek medical advice for severe or persistent symptoms, inability to keep fluids down, severe abdominal pain, signs of allergic reaction or other concerning changes.
